Clinical Trial Update: Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESA [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of peginesatide for treating anemia in dialysis patients not receiving an ESA. Results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• Peginesatide (Omontys) (peginesatide)

Snippet

Sponsor: Affymax | Conditions: Anemia, Chronic Renal Failure | Phase 2 | Status: COMPLETED | Results posted: 2012-05-30